Skip to main content
. 2009 Jun;174(6):2061–2072. doi: 10.2353/ajpath.2009.080960

Figure 8.

Figure 8

ADAM17 is expressed in podocytes and increased glomerular ADAM17 expression is detectable in patients with MN. A: Podocytes were fixed with methanol and immunofluorescence analysis were performed using a monoclonal antibody against ADAM17 and Cy3 coupled secondary antibody (red). B: ADAM17 expression in human normal kidney was visualized by monoclonal antibody against ADAM17 and Cy3 coupled secondary antibody. C: The expression of ADAM17 was visualized in biopsies of patients with MN by monoclonal ADAM17 followed by Cy3 coupled secondary antibody.